We are live on ! Find out more
APEN

Apollo Endosurgery, Inc.

Delisted

APEN was delisted on the 3rd of April, 2023.

72 hedge funds and large institutions have $239M invested in Apollo Endosurgery, Inc. in 2021 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 29 increasing their positions, 9 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

4,586% more call options, than puts

Call options by funds: $984K | Put options by funds: $21K

222% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 9

200% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 9

50% more capital invested

Capital invested by funds: $159M → $239M (+$79.9M)

31% more funds holding

Funds holding: 5572 (+17)

0% more funds holding in top 10

Funds holding in top 10: 44 (0)

Holders
72
Holders Change
+17
Holders Change %
+30.91%
% of All Funds
1.11%
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.06%
New
27
Increased
29
Reduced
9
Closed
9
Calls
$984K
Puts
$21K
Net Calls
+$963K
Net Calls Change
+$213K
Name Holding Trade Value Shares
Change
Change in
Stake
MHP
26
Manatuck Hill Partners
Connecticut
$2.15M +$147K +16,868 +7%
HIM
27
Hillsdale Investment Management
Ontario, Canada
$1.84M -$358K -41,000 -16%
Northern Trust
28
Northern Trust
Illinois
$1.54M +$160K +18,354 +11%
BCM
29
Bridgeway Capital Management
Texas
$1.39M -$205K -23,500 -12%
TDC
30
Thompson Davis & Co
Virginia
$1.35M +$1.4M +160,579 New
EI
31
EAM Investors
California
$1.18M -$613K -70,142 -33%
Millennium Management
32
Millennium Management
New York
$1.13M +$1.18M +134,532 New
NSEDCP
33
NJ State Employees Deferred Compensation Plan
New Jersey
$1.1M
Calamos Advisors
34
Calamos Advisors
Illinois
$1.08M +$1.12M +128,564 New
Russell Investments Group
35
Russell Investments Group
United Kingdom
$1.05M +$1.09M +124,741 New
Marshall Wace
36
Marshall Wace
United Kingdom
$882K -$387K -44,356 -30%
Susquehanna International Group
37
Susquehanna International Group
Pennsylvania
$751K +$504K +57,651 +183%
1CM
38
1492 Capital Management
Wisconsin
$631K +$654K +74,864 New
Citadel Advisors
39
Citadel Advisors
Florida
$619K +$413K +47,225 +180%
State Street
40
State Street
Massachusetts
$497K +$174K +19,900 +51%
Neuberger Berman Group
41
Neuberger Berman Group
New York
$422K
6CM
42
683 Capital Management
New York
$418K +$433K +49,564 New
Citigroup
43
Citigroup
New York
$360K +$373K +42,696 New
TI
44
Trexquant Investment
Connecticut
$267K +$176K +20,170 +175%
CSS
45
Cubist Systematic Strategies
Connecticut
$263K +$272K +31,145 New
AGM
46
Alpine Global Management
New York
$251K +$261K +29,828 New
Ameriprise
47
Ameriprise
Minnesota
$210K -$109K -12,500 -33%
Qube Research & Technologies (QRT)
48
Qube Research & Technologies (QRT)
United Kingdom
$199K +$206K +23,581 New
AI
49
Atom Investors
Texas
$170K +$176K +20,115 New
Balyasny Asset Management
50
Balyasny Asset Management
Illinois
$170K +$176K +20,139 New

APEN Hedge Fund Activity: Q4 2021 in Review

72 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Apollo Endosurgery, Inc. (APEN) for Q4 2021, worth a combined $239M — up 50% from $159M a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new APEN positions and 9 closed out — a net gain of 18 holders — while 29 added to existing stakes and 9 trimmed.

The largest buyer was Soleus Capital Management, opening a new position worth an estimated $20M. The largest seller was Invesco, exiting entirely with an estimated $2.67M sold.

  • 72 institutional investors held Apollo Endosurgery, Inc. (APEN) as of Q4 2021, up from 55 in Q3 2021.
  • Funds reported $239M of Apollo Endosurgery, Inc. stock for Q4 2021, up 50% quarter-over-quarter.
  • 27 funds opened new Apollo Endosurgery, Inc. positions in Q4 2021 and 9 closed out, a net change of +18 holders.
  • The largest Apollo Endosurgery, Inc. buyer in Q4 2021 was Soleus Capital Management, an estimated $20M added.
  • The largest Apollo Endosurgery, Inc. seller in Q4 2021 was Invesco, an estimated $2.67M sold.

Based on aggregated 13F filings for Q4 2021.